Webinar Alert

Vitamin K2 MK-4: the Next Opportunity in US Supplements

Thursday, April 23, 2026 : 1:00 PM EDT

Vitamin K2 MK-4: the Next Opportunity in US Supplements
img
Register Now

Vitamin K2 awareness continues to grow in the US supplements market, but most products today rely almost exclusively on MK-7. This webinar explores why MK-4 represents the next strategic opportunity for brands, particularly within emerging positioning areas such as healthy aging, brain health, and longevity.

During this session, we will review the scientific mechanisms and clinical evidence behind Vitamin K2 MK-4, its unique properties compared with other K vitamins, and its role in key health categories including bone, vascular, cognitive health, and aging.

We will also discuss formulation strategies, synergistic ingredient combinations, and positioning opportunities for US supplement brands, together with the supply and quality advantages of the SuanNutra–Menadiona partnership for the US market.


Jaime Durán

Jaime Durán
Chief Business Officer, Suannutra
Pablo García de Frutos

Pablo García de Frutos
Ph.D., Institute of Biomedical Research of Barcelona-Spanish National Research Council (IIBB-CSIC)
Sean Moloughney

Sean Moloughney
Moderator, Editor, Nutraceuticals World

Register Now
This is a free webinar, but an RSVP is required.
Even if you can't attend, RSVP anyway and we'll send you a link to watch it on-demand afterward.

 
Logo

The Science of Human-Residential Bifidobacteria: Why Origin Matters
View Now on Demand >>
Solving Taste, Solubility & Formulation Challenges with FungiFuse™ Mushroom Platform
View Now on Demand >>
LFX™ Apo-Lactoferrin: Precision Fermentation Meets Advanced Lactoferrin Science
View Now on Demand >>
Why GLP-1 Changed the Way We Think About Metabolic Health
View Now on Demand >>
DEFINING AND MARKETING THE LONGEVITY TREND: What does the Longevity category need to succeed?
View Now on Demand >>
Formulating for Metabolic Health: Decoding the Saanroo Science Behind Gut & Weight Solutions
View Now on Demand >>